((lp0
VisWord
p1
aVcase
p2
aVstops
p3
aVstem
p4
acnltk.probability
FreqDist
p5
((dp6
S'incorporation of calcium'
p7
I1
sS'co-factor'
p8
I1
sVclinical consequ
p9
I1
sVepidemiolog
p10
I2
sS'fracture risk'
p11
I1
sS'osteocalcin'
p12
I2
sVof oral anticoagulants vitamin k antagonist
p13
I2
sVcarboxyl
p14
I1
sVfractur
p15
I1
sVepidemiologic studi
p16
I2
sS'potential pharmacological effects of vka'
p17
I1
sVk antagonist
p18
I1
sS'vitamin k'
p19
I1
sVanticoagulants vitamin k antagonist
p20
I1
sVprotein
p21
I1
sS'of vka'
p22
I2
sS'affinity for'
p23
I1
sS'undercarboxylated osteocalcin'
p24
I1
sVoral anticoagul
p25
I1
sVcohort studi
p26
I1
sVk defici
p27
I1
sVthromboembolic diseas
p28
I1
sVresorpt
p29
I1
sS'skeletal effects of oral anticoagulants vitamin k'
p30
I1
sVphysical il
p31
I1
sS'vka'
p32
I2
sVoral anticoagulants vitamin k antagonist
p33
I1
sVanticoagul
p34
I1
sS'incorporation of'
p35
I1
sS'skeletal effects of oral anticoagulants vitamin'
p36
I1
sVaffin
p37
I1
sVdiseas
p38
I1
sVdefici
p39
I1
sS'risk'
p40
I1
sS'skeletal effects of'
p41
I1
sS'pharmacological effects of vka'
p42
I1
sVosteoblast
p43
I1
sVpost-translational carboxyl
p44
I1
sS'affinity for calcium'
p45
I1
sVvitamin k antagonist
p46
I1
sVcarboxylated protein
p47
I1
sS'potential pharmacological effects of'
p48
I1
sVantagonist
p49
I1
sVvitamin k defici
p50
I1
sVskeletal effects of oral anticoagulants vitamin k antagonist
p51
I1
sVconsequ
p52
I1
sS'for calcium'
p53
I1
sVill
p54
I1
sVbone resorpt
p55
I1
sS'oc'
p56
I1
sS'oa'
p57
I3
sS'calcium'
p58
I2
sS'of calcium'
p59
I1
sVincorpor
p60
I1
sVhydroxycoumarin
p61
I1
sVstudi
p62
I3
stp63
Rp64
tp65
.